Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingming Liu

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 4, 2022
Discovery of 6,7-dihydro-5H-pyrrolo[3,4-d] pyrimidine derivatives as a new class of ATR inhibitorsPei Chen, Huachao Bin, Yan Jiao, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Discovery of [1,2,3]Triazolo[4,5-<i>c</i>]quinoline Derivatives as a New Class of Ataxia-Telangiectasia Mutated Kinase InhibitorsShiyu Zhang, Pei Zhou, Jingming Liu, et al.
Nature Communications|April 10, 2026
Massive barcode-free chemical screenings enable the discovery of bioactive macrocycles with passive membrane permeabilityJ Miguel Mata, Jingming Liu, Sean M McKenna, et al.
Journal of Chemical Information and Modeling|October 3, 2022
Discovery of Small Molecule Agonist of Gonadotropin-Releasing Hormone Receptor (GnRH1R)Xin Yang, Guifeng Lin, Anjie Xia, et al.
European Journal of Medicinal Chemistry|June 5, 2025
Discovery of a potent, broad-spectrum and in vivo effective deuterated tetrazole CYP51 inhibitorZirui Luo, Rongrong Liu, Yixiang Sun, et al.
Nature Chemical Biology|May 31, 2022
Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1Xin Yang, Xuehui Wang, Zheng Xu, et al.
Cancer Science|April 30, 2025
A Contrast-Enhanced Ultrasound Cine-Based Deep Learning Model for Predicting the Response of Advanced Hepatocellular Carcinoma to Hepatic Arterial Infusion Chemotherapy Combined With Systemic TherapiesXu Han, Chuan Peng, Si-Min Ruan, et al.
Journal of Medicinal Chemistry|February 23, 2023
Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory PainJinshan Nan, Jingming Liu, Guifeng Lin, et al.
ACS Chemical Biology|November 18, 2025
Evaluating BindCraft for Generative Design of High-Affinity PeptidesMike Filius, Thanasis Patsos, Hugo Minnee, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2024
Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1Siyuan Shen, Chao Wu, Guifeng Lin, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|March 4, 2022
Discovery of 6,7-dihydro-5H-pyrrolo[3,4-d] pyrimidine derivatives as a new class of ATR inhibitorsPei Chen, Huachao Bin, Yan Jiao, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Discovery of [1,2,3]Triazolo[4,5-<i>c</i>]quinoline Derivatives as a New Class of Ataxia-Telangiectasia Mutated Kinase InhibitorsShiyu Zhang, Pei Zhou, Jingming Liu, et al.
Nature Communications|April 10, 2026
Massive barcode-free chemical screenings enable the discovery of bioactive macrocycles with passive membrane permeabilityJ Miguel Mata, Jingming Liu, Sean M McKenna, et al.
Journal of Chemical Information and Modeling|October 3, 2022
Discovery of Small Molecule Agonist of Gonadotropin-Releasing Hormone Receptor (GnRH1R)Xin Yang, Guifeng Lin, Anjie Xia, et al.
European Journal of Medicinal Chemistry|June 5, 2025
Discovery of a potent, broad-spectrum and in vivo effective deuterated tetrazole CYP51 inhibitorZirui Luo, Rongrong Liu, Yixiang Sun, et al.
Nature Chemical Biology|May 31, 2022
Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1Xin Yang, Xuehui Wang, Zheng Xu, et al.
Cancer Science|April 30, 2025
A Contrast-Enhanced Ultrasound Cine-Based Deep Learning Model for Predicting the Response of Advanced Hepatocellular Carcinoma to Hepatic Arterial Infusion Chemotherapy Combined With Systemic TherapiesXu Han, Chuan Peng, Si-Min Ruan, et al.
Journal of Medicinal Chemistry|February 23, 2023
Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory PainJinshan Nan, Jingming Liu, Guifeng Lin, et al.
ACS Chemical Biology|November 18, 2025
Evaluating BindCraft for Generative Design of High-Affinity PeptidesMike Filius, Thanasis Patsos, Hugo Minnee, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2024
Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1Siyuan Shen, Chao Wu, Guifeng Lin, et al.
Pageof 5